A detailed history of Rfg Advisory, LLC transactions in Pro Qr Therapeutics N.V. stock. As of the latest transaction made, Rfg Advisory, LLC holds 42,000 shares of PRQR stock, worth $112,140. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42,000
Previous 32,000 31.25%
Holding current value
$112,140
Previous $53,000 43.4%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$1.64 - $2.24 $16,400 - $22,400
10,000 Added 31.25%
42,000 $76,000
Q1 2024

Apr 11, 2024

BUY
$1.89 - $2.85 $60,480 - $91,200
32,000 New
32,000 $73,000

Others Institutions Holding PRQR

About ProQR Therapeutics N.V.


  • Ticker PRQR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,362,096
  • Market Cap $191M
  • Description
  • ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...
More about PRQR
Track This Portfolio

Track Rfg Advisory, LLC Portfolio

Follow Rfg Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rfg Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rfg Advisory, LLC with notifications on news.